Agency Forms Undergoing Paperwork Reduction Act Review, 55808-55809 [2022-19557]
Download as PDF
<![CDATA[
55808
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–19565 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1128]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘State
Unintentional Drug Overdose Reporting
System (SUDORS)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on April 18,
2022 to obtain comments from the
public and affected agencies. CDC
received one public comment related to
the previous notice. This notice serves
to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
State Unintentional Drug Overdose
Reporting System (SUDORS) (OMB
Control No. 0920–1128, Exp. 1/31/
2023)—Revision—National Center for
Injury Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
There has been a rapid increase in
opioid overdose deaths since 2013. In
the United States, more people are now
dying of drug overdose than automobile
crashes, although opioids—both opioid
pain relievers (OPRs) and illicit forms
such as heroin—are also a major factor
in overdose-related automobile crashes.
On October 26, 2017, the U.S.
Department of Health and Human
Services (HHS) declared the opioid
overdose epidemic to be a national
public health emergency (PHE).
CDC established the State
Unintentional Drug Overdose Reporting
System (SUDORS) in order to detect
new trends in fatal unintentional drug
overdoses, support targeting of drug
overdose prevention efforts, and assess
the progress of the HHS initiative to
reduce opioid misuse and overdoses.
Respondents are state- or jurisdictionlevel health departments. The SUDORS
surveillance system generates detailed,
timely public health information on
unintentional, fatal opioid-related drug
overdoses and has been used to inform
prevention and response efforts at the
national, state, and local levels.
SUDORS consolidates and supplements
information available to health
departments, including vital statistics
and records created by medical
examiners and coroners (ME/C).
SUDORS is built on a web-based
software platform and a collaborative
surveillance and data integration model
developed by CDC and health
departments to improve understanding
of homicide, suicide, undetermined
deaths, and unintentional firearm
deaths (National Violent Death
Reporting System (NVDRS), OMB
Control No. 0920–0607).
Through SUDORS, CDC currently
collects information that is not provided
on death certificates, such as whether
the drug(s) causing the overdoses were
injected or taken orally; a toxicology
report on the decedent, if available; and
risk factors for fatal drug overdoses
including previous drug overdoses,
decedent’s mental health, and whether
the decedent recently exited a treatment
program. Without this information,
efforts to prevent drug overdose deaths
are often based on limited information
available on the death certificate and
anecdotal evidence.
OMB approval is requested for three
years. Participating states and
jurisdictions will continue to report
SUDORS information to CDC through a
module in the NVDRS web-based
platform. State- and jurisdiction-level
public health departments will be
funded to abstract standardized data
elements from ME/C reports as well as
death certificates. During the next three
years, CDC will remove data collection
activities in Puerto Rico, and update the
burden estimate to reflect the increase
in drug overdose deaths.
CDC requests OMB approval for an
estimated 43,631 annualized burden
hours. There are no costs to respondents
other than their time.
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Public Agencies ..............................................
Retrieving and refiling records .......................
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
E:\FR\FM\12SEN1.SGM
51
12SEN1
Total number
of responses
per
respondent
1,711
Average
burden
per response
(in hours)
30/60
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–19557 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1338; Docket No. CDC–2022–
0106]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled, Evaluation of
the Effectiveness of the Training and
Education Modules in the North
American Fatigue Management
Program. This is an observational study
evaluating 180 long-haul and regional
truck drivers in a naturalistic driving
study over eight months, using
questionnaires, in-vehicle monitor
system, Actigraphy devices, and
smartphones for data collection.
DATES: CDC must receive written
comments on or before November 14,
2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0106 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all Federal
comments through the Federal
eRulemaking portal
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of the Effectiveness of the
Training and Education Modules in the
North American Fatigue Management
Program (OMB Control No. 0920–1338,
Exp. 06/30/2023)—Extension—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
55809
Background and Brief Description
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
and prevention. Reducing fatiguerelated crashes is one of the top 10
changes needed to reduce transportation
accidents and save lives identified by
the National Transportation Safety
Board (NTSB) and a National
Occupational Research Agenda (NORA)
priority.
Fatigue is a preventable cause of truck
crashes. The North American Fatigue
Management Program (NAFMP) was
developed by the Federal Motor Carrier
Safety Administration, Transport
Canada, and other entities to address
commercial motor vehicle (CMV) driver
fatigue through a comprehensive
approach that delivers prevention
information to carriers, dispatchers,
drivers, and family members. In 2015,
the National Academy of Sciences
published the report ‘‘Commercial
motor vehicle driver fatigue, long-term
health, and highway safety research
needs’’ that identified the need for fully
evaluating the NAFMP so that
recommendations for implementation of
NAFMP are supported by scientific
evidence. NIOSH is collaborating with
the Federal Motor Carrier Safety
Administration (FMCSA) to ensure the
success of the proposed study. NIOSH is
requesting an extension to account for
the additional time necessary to recruit
more respondents.
Data will be collected from CMV
drivers (hereafter referred to as ‘‘driver’’)
during their application to participate in
the study, briefing session, study
participation, and debriefing session.
Data collection will primarily focus on
driving performance, sleep, and
sleepiness. These outcomes will be
compared between pre-rollout of the
NAFMP (in which drivers will operate
as they did before their participation in
the study) and post-rollout of the
NAFMP training and education modules
(in which drivers and managers will
operate with increased knowledge,
strategies, and techniques to reduce
their fatigue). All drivers interested in
participating in the study may complete
the application. A briefing session will
be scheduled with drivers who are
found eligible for the study. During the
briefing session, drivers who provide
informed consent will be enrolled in the
study. Drivers will have a debriefing
session if a driver chooses to withdraw
from the study early or upon completion
of the eight-month participation period.
The sample of drivers in the study
will include those employed as drivers
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 87, Number 175 (Monday, September 12, 2022)]
[Notices]
[Pages 55808-55809]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19557]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1128]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``State Unintentional Drug Overdose Reporting
System (SUDORS)'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
April 18, 2022 to obtain comments from the public and affected
agencies. CDC received one public comment related to the previous
notice. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
State Unintentional Drug Overdose Reporting System (SUDORS) (OMB
Control No. 0920-1128, Exp. 1/31/2023)--Revision--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
There has been a rapid increase in opioid overdose deaths since
2013. In the United States, more people are now dying of drug overdose
than automobile crashes, although opioids--both opioid pain relievers
(OPRs) and illicit forms such as heroin--are also a major factor in
overdose-related automobile crashes. On October 26, 2017, the U.S.
Department of Health and Human Services (HHS) declared the opioid
overdose epidemic to be a national public health emergency (PHE).
CDC established the State Unintentional Drug Overdose Reporting
System (SUDORS) in order to detect new trends in fatal unintentional
drug overdoses, support targeting of drug overdose prevention efforts,
and assess the progress of the HHS initiative to reduce opioid misuse
and overdoses. Respondents are state- or jurisdiction-level health
departments. The SUDORS surveillance system generates detailed, timely
public health information on unintentional, fatal opioid-related drug
overdoses and has been used to inform prevention and response efforts
at the national, state, and local levels. SUDORS consolidates and
supplements information available to health departments, including
vital statistics and records created by medical examiners and coroners
(ME/C). SUDORS is built on a web-based software platform and a
collaborative surveillance and data integration model developed by CDC
and health departments to improve understanding of homicide, suicide,
undetermined deaths, and unintentional firearm deaths (National Violent
Death Reporting System (NVDRS), OMB Control No. 0920-0607).
Through SUDORS, CDC currently collects information that is not
provided on death certificates, such as whether the drug(s) causing the
overdoses were injected or taken orally; a toxicology report on the
decedent, if available; and risk factors for fatal drug overdoses
including previous drug overdoses, decedent's mental health, and
whether the decedent recently exited a treatment program. Without this
information, efforts to prevent drug overdose deaths are often based on
limited information available on the death certificate and anecdotal
evidence.
OMB approval is requested for three years. Participating states and
jurisdictions will continue to report SUDORS information to CDC through
a module in the NVDRS web-based platform. State- and jurisdiction-level
public health departments will be funded to abstract standardized data
elements from ME/C reports as well as death certificates. During the
next three years, CDC will remove data collection activities in Puerto
Rico, and update the burden estimate to reflect the increase in drug
overdose deaths.
CDC requests OMB approval for an estimated 43,631 annualized burden
hours. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Total number Average burden
Type of respondent Form name Number of of responses per response
respondents per respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Public Agencies....................... Retrieving and refiling 51 1,711 30/60
records.
----------------------------------------------------------------------------------------------------------------
[[Page 55809]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-19557 Filed 9-9-22; 8:45 am]
BILLING CODE 4163-18-P
